Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $75.62 million. The enterprise value is $193.81 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 36.18 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | 36.18M |
| Shares Outstanding | 36.18M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | -37.88% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 3.83% |
| Float | 11.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.82 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 35.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
| Current Ratio | 0.19 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.57% |
| Return on Capital (ROIC) | -27.93% |
| Revenue Per Employee | $82,833 |
| Profits Per Employee | -$626,712 |
| Employee Count | 66 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.86% in the last 52 weeks. The beta is 0.80, so ARMP's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -5.86% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 2.80 |
| Relative Strength Index (RSI) | 40.94 |
| Average Volume (20 Days) | 11,580 |
Short Selling Information
The latest short interest is 4,540, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 4,540 |
| Short Previous Month | 3,372 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 0.86 |
Income Statement
In the last 12 months, ARMP had revenue of $5.47 million and -$41.36 million in losses. Loss per share was -$1.15.
| Revenue | 5.47M |
| Gross Profit | -28.30M |
| Operating Income | -41.48M |
| Pretax Income | -79.58M |
| Net Income | -41.36M |
| EBITDA | -40.24M |
| EBIT | -41.48M |
| Loss Per Share | -$1.15 |
Full Income StatementBalance Sheet
The company has $17.14 million in cash and $135.33 million in debt, giving a net cash position of -$118.19 million or -$3.27 per share.
| Cash & Cash Equivalents | 17.14M |
| Total Debt | 135.33M |
| Net Cash | -118.19M |
| Net Cash Per Share | -$3.27 |
| Equity (Book Value) | -50.97M |
| Book Value Per Share | -1.41 |
| Working Capital | -95.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$37.73 million and capital expenditures -$4.36 million, giving a free cash flow of -$42.09 million.
| Operating Cash Flow | -37.73M |
| Capital Expenditures | -4.36M |
| Free Cash Flow | -42.09M |
| FCF Per Share | -$1.16 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -758.66% |
| Pretax Margin | -756.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -996.19% |